Lentigo maligna (or LM) is a type of skin cancer that affects the pigmented cells in the outer layer of the skin. It usually appears in areas of the skin that have been exposed to ultraviolet rays from sunlight, such as the face, ears, and arms. LM is considered an early stage of melanoma, and if left untreated can lead to other more serious conditions. In this article, we will discuss all aspects of Lentigo maligna: what it is, its symptoms and treatment options. We will also explore why it’s so important to catch it early and how to protect yourself from getting it in the first place.
Lentigo maligna is a type of skin cancer that most often affects people over the age of 50. It is more common in women than men. The cancer develops slowly, over months or years, and usually begins as a flat, brown or black spot on the skin.
The spot may be small at first, but it can grow larger and darker over time. Lentigo maligna is most commonly found on the face, especially on the forehead, temple, cheek, or lip. It can also occur on other parts of the body that get a lot of sun exposure, such as the arms, chest, and legs.
A flat, brown or black Spot on the skin that gradually gets larger and darker
itching
A burning sensation
tenderness
crusting
bleeding
Lentigo maligna is usually diagnosed with a biopsy, which involves taking a small sample of tissue from the affected area for examination under a microscope. Treatment options for lentigo maligna include topical chemotherapy, radiation therapy, surgery, or a combination of these treatments.
Lentigo maligna is a form of melanoma, the deadliest type of skin cancer. It is most often found on the face, head, or neck. It can also occur on the arms and legs. The main symptom of lentigo maligna is a dark brown or black discoloration of the skin. The discoloration may be irregular in shape and size. It may also be accompanied by itching, burning, or bleeding. If you have any of these symptoms.Early diagnosis and treatment are critical to preventing the spread of this cancer.
There are a few different treatment options available for lentigo maligna. These include surgical removal, radiation therapy, and topical chemotherapy.
Surgical removal is the most common treatment option and involves removing the affected skin with a scalpel. This is usually done as an outpatient procedure and has a high success rate.
Radiation therapy uses high-energy waves to destroy cancer cells. It can be used as a primary treatment or in combination with surgery. Topical chemotherapy uses drugs that are applied to the skin to kill cancer cells. This option is often used when surgery is not an option or the cancer has spread to other parts of the body.
Lentigo maligna is a type of skin cancer that tends to appear on areas of the body exposed to sunlight over long periods. Although it can be difficult to detect, knowing the signs and symptoms of this condition is important for early diagnosis and treatment. If you have any concerns about your skin or believe you may be experiencing any signs or symptoms of lentigo maligna, make an appointment with a dermatologist as soon as possible for further evaluation.
Read more such content on @ Hidoc Dr | Medical Learning App for Doctors
1.
Le cancer et le COVID ont conduit le patient à une double transplantation de poumon.
2.
Effective for localizing small, non-palpable breast lesions is ultrasound-guided localization with magnetic seeds.
3.
Long-term study links chronic conditions in midlife to higher cancer risk and mortality
4.
Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients
5.
When does a melanoma metastasize? Implications for management
1.
Unlocking the Mysteries of Reticulocyte Counts: A Guide to Understanding Your Blood Results
2.
The Checkpoint Architect: Unraveling the Mechanisms of PD-L1 Regulation for the Next Generation of Small-Molecule Therapies
3.
Screening Efficacy, Molecular Precision, and Therapeutic Revolutions in Lung Cancer 2025
4.
Genetic Testing in Cancer Prevention: BRCA Mutations and Lynch Syndrome Unlocked
5.
Transforming Cancer Care: CAR T-Cell Therapy for Relapsed/Refractory NHL and ALL
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
4.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation